TickerFacts.

Vitaspring Biomedical Co. Ltd. (VSBC): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$4.43M
As of 2026-01-31
-$4.66M
As of 2026-07-31
$1.58M2017-01-31: $3.0K2018-01-31: -$3.4K2019-01-31: -$6.9K2021-01-31: $96.4K2022-01-31: $1.58M2023-01-31: -$2.40M2024-01-31: -$3.35M2025-01-31: -$4.02M2026-01-31: -$4.43M-$4.43M
2017-01-31 Shareholders' Equity (USD) 2026-01-31
Period endedShareholders' EquityChange YoYSource filing
2026-01-31-$4.43Mn/m2026-06-17, Balance as of period end
2025-01-31-$4.02Mn/m2026-06-17, Balance as of period end
2024-01-31-$3.35Mn/m2026-06-08, Balance as of period end
2023-01-31-$2.40Mn/m2026-03-12, Balance as of period end
2022-01-31$1.58Mn/m2025-12-01, Balance as of period end
2021-01-31$96.4Kn/a2022-05-03, Balance as of period end
No annual figure between 2019-01-31 and 2021-01-31.
2019-01-31-$6.9Kn/m2020-06-09, Balance as of period end
2018-01-31-$3.4Kn/m2019-04-26, Balance as of period end
2017-01-31$3.0Kn/a2018-05-16, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31-$4.43Mn/m
NRC Health (NRC)2025-12-31$13.99M-55.3%
Incyte Corp (INCY)2025-12-31$5.17B+49.9%
Icon PLC (ICLR)2025-12-31$9.19B-2.6%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.17B-8.6%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$1.16Mn/m
Iqvia Holdings Inc. (IQV)2025-12-31$6.63B+9.3%
iSpecimen Inc. (ISPC)2025-12-31$3.09M-6.7%

Compare VSBC, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗